Takeda
Transforming lives through science
- B2B
- Has physical offices
- Publicly traded
- Manufacturing
- Multi-product
- Sales-led purchase
About Takeda
The company is committed to transforming lives by advancing science, focusing on patient needs, and setting new standards in healthcare
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,000+ employees
- Headquarters
- Tokyo, Japan
- Founded
- 1781
- Revenue
- JPY 4506BFY2026, publicly reported
- Website
- takeda.com
Takeda competitors
- Otsuka Holdings Co., Ltd.
Tokyo-based services provider
Direct competitor
Jobs at Takeda
- Digital Content Lead, Omnichannel Operations & Analytics - Medical Affairs
- Director, Modality Excellence - Indirect Processes, Quality, Engineering & Maintenance and Warehouse
- EHS Specialist, Osaka site/大阪工場 環境安全衛生管理担当者（課長代理)
- Head of EHS (m/w/d)
- Principal Engineer - Data Visualization & Analytics
- GCM Transition Lead (Director) - Manufacturing and Supply Chain
- Head of Analytical Data & Statistics
- Associate Director, Vaccine DS Manufacturing / ワクチン原薬製造 主席部員
Takeda in the news
- Takeda partners with Innovent: what USD 1.20 billion means for Innovent Biologics stock
Takeda entered a global oncology partnership with Innovent Biologics, involving a USD 1.20 billion upfront payment to Innovent, for the development, manufacturing, and commercialization of IBI363 and IBI343.
- Takeda Pharmaceuticals' Psoriasis Pill Zasocitinib
Takeda's AI-aided psoriasis pill, zasocitinib, showed superior efficacy in a Phase 3 trial and is now under FDA priority review for potential approval.
- Corus International receives $6.4 million grant from Takeda to reduce climate-related health risks in Nepal
Corus International received a $6.4 million grant from Takeda to mitigate climate-related health risks in Nepal.
- Takeda Pharmaceutical (TSE:4502) Could Be 13% Undervalued After Fresh Psoriasis Trial Data
Takeda Pharmaceutical's new psoriasis drug data suggests it is undervalued, with future growth expected from its pipeline despite recent stock cooling.
- Takeda Pharmaceuticals (NYSE:TAK): The Only Japanese Pharma Now Enters The Three Years That Will Define Its Future
Takeda Pharmaceuticals is entering a pivotal three-year period where its global transformation and new product pipeline are expected to deliver significant earnings growth.
Takeda at a glance
Takeda is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Tokyo, Japan.
Takeda was founded in 1781.
Takeda has 10,000+ employees.
Takeda's revenue is JPY 4506B (FY2026, publicly reported).
Takeda is hiring: 8 recent open roles, including Digital Content Lead, Omnichannel Operations & Analytics - Medical Affairs, Director, Modality Excellence - Indirect Processes, Quality, Engineering & Maintenance and Warehouse, EHS Specialist, Osaka site/大阪工場 環境安全衛生管理担当者（課長代理).
Selling to companies like Takeda?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies